Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Douglas

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Lancet (London, England)|May 17, 1980
Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant diseaseD L Douglas, T Duckworth, R G Russell, et al.
British Journal of Cancer|May 1, 1985
Treatment of malignant hypercalcaemia with clodronateR C Percival, A D Paterson, A J Yates, et al.
Arthritis and Rheumatism|October 1, 1980
Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of boneD L Douglas, T Duckworth, J A Kanis, et al.
British Medical Journal (Clinical Research Ed.)|February 19, 1983
Drug treatment of primary hyperparathyroidism: use of clodronate disodiumD L Douglas, J A Kanis, A D Paterson, et al.
Metabolic Bone Disease & Related Research|January 1, 1981
Biochemical markers of bone turnover in Paget's diseaseR G Russell, D J Beard, E C Cameron, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Lancet (London, England)|May 17, 1980
Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant diseaseD L Douglas, T Duckworth, R G Russell, et al.
British Journal of Cancer|May 1, 1985
Treatment of malignant hypercalcaemia with clodronateR C Percival, A D Paterson, A J Yates, et al.
Arthritis and Rheumatism|October 1, 1980
Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of boneD L Douglas, T Duckworth, J A Kanis, et al.
British Medical Journal (Clinical Research Ed.)|February 19, 1983
Drug treatment of primary hyperparathyroidism: use of clodronate disodiumD L Douglas, J A Kanis, A D Paterson, et al.
Metabolic Bone Disease & Related Research|January 1, 1981
Biochemical markers of bone turnover in Paget's diseaseR G Russell, D J Beard, E C Cameron, et al.
Pageof 4